ES2093246T3 - Compuestos de benzazepina terapeuticos. - Google Patents

Compuestos de benzazepina terapeuticos.

Info

Publication number
ES2093246T3
ES2093246T3 ES92901758T ES92901758T ES2093246T3 ES 2093246 T3 ES2093246 T3 ES 2093246T3 ES 92901758 T ES92901758 T ES 92901758T ES 92901758 T ES92901758 T ES 92901758T ES 2093246 T3 ES2093246 T3 ES 2093246T3
Authority
ES
Spain
Prior art keywords
treatment
therapeutic
formula
neurological disorders
benzazepine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901758T
Other languages
English (en)
Inventor
Marc Jerome Chapdelaine
Charles David Mclaren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2093246T3 publication Critical patent/ES2093246T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

SE PRESENTA UN METODO PARA EL TRATAMIENTO DE ENFERMEDADES NEUROLOGICAS, QUE COMPRENDE LA ADMINISTRACION A UN MAMIFERO DE UNA CANTIDAD EFECTIVA DE TRATAMIENTO DE UN COMPUESTO DE LA FORMULA I O DE LA FORMULA II, EN LAS QUE R1, R2, R3 Y R4 SE SELECCIONAN INDEPENDIENTEMENTE ENTRE: HIDROGENO (13C)PERFLUOROALQUIL, HALO, NITRO, Y CIANO; R5 ES UN GRUPO (15C)ALQUIL; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. TAMBIEN SE SUMINISTRAN COMPUESTOS Y COMPOSICIONES FARMACEUTICAS ADECUADAS PARA EL TRATAMIENTO DE ENFERMEDADES NEUROLOGICAS.
ES92901758T 1991-01-02 1991-12-30 Compuestos de benzazepina terapeuticos. Expired - Lifetime ES2093246T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100028A GB9100028D0 (en) 1991-01-02 1991-01-02 Compounds

Publications (1)

Publication Number Publication Date
ES2093246T3 true ES2093246T3 (es) 1996-12-16

Family

ID=10687882

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901758T Expired - Lifetime ES2093246T3 (es) 1991-01-02 1991-12-30 Compuestos de benzazepina terapeuticos.

Country Status (22)

Country Link
US (3) US5254683A (es)
EP (1) EP0517876B1 (es)
JP (1) JP3034604B2 (es)
KR (1) KR100229049B1 (es)
AT (1) ATE144423T1 (es)
AU (1) AU650086B2 (es)
CA (1) CA2058593A1 (es)
CZ (1) CZ299292A3 (es)
DE (1) DE69122858T2 (es)
DK (1) DK0517876T3 (es)
ES (1) ES2093246T3 (es)
FI (1) FI104071B (es)
GB (2) GB9100028D0 (es)
GR (1) GR3021440T3 (es)
HU (2) HU212269B (es)
IE (1) IE920009A1 (es)
IL (1) IL100484A (es)
NO (1) NO300497B1 (es)
NZ (1) NZ241197A (es)
PL (1) PL166481B1 (es)
WO (1) WO1992011854A1 (es)
ZA (1) ZA9223B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
CA2115792C (en) 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5476933A (en) * 1994-11-16 1995-12-19 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Azepine synthesis via a diels-alder reaction
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
FR2796552A1 (fr) 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau
JPWO2016199789A1 (ja) * 2015-06-08 2018-03-29 国立大学法人名古屋大学 トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340334A (en) * 1970-07-06 1973-12-12 Rees A H Synthesis of benzazetropolones and hence of kynurenic acids
CY1403A (en) * 1981-08-11 1987-12-18 Ciba Geigy Ag Benzazepin-2-ones
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
KR0167349B1 (ko) * 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof

Also Published As

Publication number Publication date
KR100229049B1 (ko) 1999-11-01
FI104071B1 (fi) 1999-11-15
US5541319A (en) 1996-07-30
GB9127498D0 (en) 1992-02-19
HU212269B (en) 1996-07-29
IL100484A (en) 1997-02-18
GB2251616B (en) 1995-01-11
US5446039A (en) 1995-08-29
GR3021440T3 (en) 1997-01-31
DE69122858D1 (de) 1996-11-28
PL166481B1 (en) 1995-05-31
CZ299292A3 (en) 1993-01-13
AU9134091A (en) 1992-08-17
EP0517876B1 (en) 1996-10-23
GB9100028D0 (en) 1991-02-20
DE69122858T2 (de) 1997-02-20
DK0517876T3 (da) 1997-04-01
EP0517876A1 (en) 1992-12-16
IE920009A1 (en) 1992-07-15
AU650086B2 (en) 1994-06-09
HU9202618D0 (en) 1992-10-28
FI923759A (fi) 1992-08-20
JP3034604B2 (ja) 2000-04-17
US5254683A (en) 1993-10-19
CA2058593A1 (en) 1992-07-03
NO300497B1 (no) 1997-06-09
FI104071B (fi) 1999-11-15
NZ241197A (en) 1994-10-26
NO923413L (no) 1992-09-01
IL100484A0 (en) 1992-09-06
WO1992011854A1 (en) 1992-07-23
HU211466A9 (en) 1995-11-28
GB2251616A (en) 1992-07-15
NO923413D0 (no) 1992-09-01
PL295932A1 (en) 1993-10-04
ZA9223B (en) 1992-09-30
JPH07502007A (ja) 1995-03-02
ATE144423T1 (de) 1996-11-15
FI923759A0 (fi) 1992-08-20
HUT64309A (en) 1993-12-28

Similar Documents

Publication Publication Date Title
MY109737A (en) Treatment and compounds.
DE3260529D1 (en) Therapeutically useful 1-alkyl-2-aminotetralin derivatives
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
ATE5961T1 (de) N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FI923662A0 (fi) Terapeutiska medel.
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
MY108455A (en) Therapeutic benzazapine compounds.
PT100641A (pt) Processo de tratamento com benzazepinas, composicoes farmaceuticas que contem estas benzazepinas, compostos benzazepinicos e processo para a sua preparacao
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517876

Country of ref document: ES